A3 adenosine receptor activation attenuates neutrophil function and neutrophil-mediated reperfusion injury

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 277, Issue 5 46-5, 1999, Pages

  Jordan, James E ^a,c   Thourani, Vinod H ^a   Auchampach, John A ^b   Robinson, Jill A ^a   Wang, Ning Ping ^a   Vinten Johansen, Jakob ^a  

^a Carlyle Fraser Heart Center   (United States)

^b University of Louisville School of Medicine   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

CD18; Endothelial adherence; Myeloperoxidase; Superoxide

Indexed keywords

ADENOSINE A3 RECEPTOR; MYELOPEROXIDASE;

ANIMAL TISSUE; ARTICLE; CELL INTERACTION; DOG; ENZYME RELEASE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; LEUKOCYTE ADHERENCE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY;

EID: 0032712049     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1999.277.5.h1895     Document Type: Article

References (43)

1. 3 receptor involvement. Cardiovasc. Res. 28: 1049-1056, 1994.
2. ATP channels, and ischemic preconditioning in dogs. Am. J. Physiol. 264 (Heart Circ. Physiol. 33): H1327-H1336, 1993.
3. 2b receptor. Mol. Pharmacol. 52: 846-860, 1997.
4. 6-(3-iodobenzyl)adenosine-5′-N-methyluronamide protects against myocardial stunning and infarction without hemodynamic changes in conscious rabbits. Circ. Res. 80: 800-809, 1997.
5. 3 receptors. J. Immunol. 158: 5400-5408, 1997.
6. Bouma, M. G., F. A. van dan Wildenberg, and W. A. Buurman. Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells. Am. J. Physiol. 270 (Cell Physiol. 39): C522-C529, 1996.
7. 2 receptor on human neutrophils. J. Immunol. 135: 1366-1371, 1985.
8. Cullen, B. R. Use of eukaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol. 152: 684-704, 1987.
9. Ely, E. W., M. C. Seeds, F. H. Chilton, and D. A. Bass. Neutrophil release of arachidonic acid, oxidants, and proteinases: causally related or independent. Biochim. Biophys. Acta 1258: 135-144, 1995.
10. 2-receptor mechanism (Abstract). FASEB J. 10: A611, 1996.
11. 3 receptor activation in rats. Eur. J. Pharmacol. 298: 293-297, 1996.
12. 3 receptors. J. Pharmacol. Exp. Ther. 280: 122-128, 1997.
13. 3 receptors in mediating physiological or pharmacological protection from ischemic myocardial injury in the rabbit heart. J. Mol. Cell. Cardiol. 30: 579-585, 1998.
14. 3-adenosine receptors: design of selective ligands and therapeutic prospects. Drugs Future 20: 689-699, 1995.
15. 3 adenosine receptor-selective antagonists. Neuropharmacology 36: 1157-1165, 1997.
16. 3 adenosine receptor activation reduces PMN-endothelial cell interaction without effect on free radicals and degranulation (Abstract). Circulation 98: 1-666, 1998.
17. 3 adenosine receptors. J. Med. Chem. 37: 3614-3621, 1994.
18. Lasley, R. D., and R. M. Mentzer, Jr. Protective effects of adenosine in the reversibly injured heart. Ann. Thorac. Surg. 60: 843-846, 1995.
19. Lefer, A. M., B. Campbell, R. Scalia, and D. J. Lefer. Synergism between platelets and neutrophils in provoking cardiac dysfunction after ischemia and reperfusion. Role of selectins. Circulation 98: 1322-1328, 1998.
20. Lefer, A. M., X.-L. Ma, A. Weyrich, and D. J. Lefer. Endothelial dysfunction and neutrophil adherence as critical events in the development of reperfusion injury. Agents Actions Suppl. 41: 127-135, 1993.
21. 3 receptors: pharmacological properties, species differences and receptor functions. Trends Pharmacol. Sci. 15: 298-306, 1994.
22. 3 adenosine receptor with widespread tissue distribution. Mol. Pharmacol. 44: 524-532, 1993.
23. 3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart. Cardiovasc. Res. 28: 1057-1061, 1994.
24. Ma, X.-L., D. J. Lefer, A. M. Lefer, and R. Rothlein. Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion. Circulation 86: 937-946, 1992.
25. McGarrity, S. T., A. H. Stephenson, and R. O. Webster. Regulation of human neutrophil functions by adenine nucleotides. J. Immunol. 142: 1986-1994, 1989.
26. 1 receptor system. Cardiovasc. Res. 27: 28-35, 1993.
27. Meyerhof, W., R. Muller-Brechlin, and D. Richter. Molecular cloning of a novel putative G-protein coupled receptor expressed during rat spermiogenesis. FEBS Lett. 284: 155-160, 1991.
28. 1 receptor antagonist, KW-3902. Jpn. J. Pharmacol. 58, Suppl. I: 194-195, 1992.
29. Myers, M. L., C. Webb, M. Moffatt, D. McIver, and R. Del Maestro. Activated neutrophils impair rabbit heart recovery after hypothermia global ischemia. Ann. Thorac. Surg. 53: 247-252, 1992.
30. Rice, P. J., S. C. Armstrong, and C. E. Ganote. Concentration-response relationships for adenosine agonists during preconditioning of rabbit cardiomyocytes. J. Mol. Cell. Cardiol. 28: 1355-1365, 1996.
31. Salvatore, C. A., M. A. Jacobson, H. E. Taylor, J. Linden, and R. G. Johnson. Molecular cloning and characterization of the human AS adenosine receptor. Proc. Natl. Acad. Sci. USA 90: 10365-10369, 1993.
32. Shandelya, S. M., P. Kuppusamy, M. L. Weisfeldt, and J. L. Zweier. Evaluation of the role of polymorphonuclear leukocytes on contractile function in myocardial reperfusion injury. Evidence for plasma-mediated leukocyte activation. Circulation 87: 536-546, 1993.
33. Stowell, C. P., T. B. Kuhlenschmidt, and C. A. Hoppe. A fluorescamine assay for submicrogram quantities of protein in the presence of Triton X-100. Anal. Biochem. 85: 572-580, 1978.
34. 3 receptors. J. Clin. Invest. 98: 1773-1779, 1996.
35. 3 receptor stimulation reduces ischemic myocardial injury in the rabbit heart. Cardiovasc. Res. 33: 410-415, 1997.
36. ATP channel activation. Cardiovasc. Res. 40: 138-145, 1998.
37. Vinten-Johansen, J., and Z.-Q. Zhao. Myocardial protection from reperfusion injury with adenosine. In: Adenosine: Cardioprotection and Clinical Application, edited by R. M. Mentzer, Jr., M. Kitakaze, J. Downey, and M. Hori. Boston, MA: Kluwer Academic, 1997, p. 49-70.
38. 3 receptors mediates preconditioning of isolated cardiac myocytes. Eur. J. Pharmacol. 320: 241-248, 1997.
39. Williams, M. W., J. E. Jordan, A. Z. Fernandez, Z.-Q. Zhao, and J. Vinten-Johansen. Adenosine (ADO) inhibits unactivated neutrophil (PMN) adherence to thrombin stimulated coronary vascular endothelium (EC) by a P-selectin mechanism (Abstract). FASEB J. 10: A280, 1996.
40. Zhao, Z.-Q., D. S. McGee, K. Nakanishi, C. F. Toombs, W. E. Johnston, M. S. Ashar, and J. Vinten-Johansen. Receptor-mediated cardioprotective effects of endogenous adenosine are exerted primarily during reperfusion after coronary occlusion in the rabbit. Circulation 88: 709-719, 1993.
41. 1-receptor mediated myocardial infarct size reduction by endogenous adenosine is exerted primarily during ischaemia. Cardiovasc. Res. 28: 270-279, 1994.
42. 2-receptor activation inhibits neutrophil-mediated injury to coronary endothelium. Am. J. Physiol. 271 (Heart Circ. Physiol. 40): H1456-H1464, 1996.
43. 3 adenosine receptor. Proc. Natl. Acad. Sci. USA 89: 7432-7436, 1992.